Literature DB >> 24323981

What lies beyond del(5q) in myelodysplastic syndrome?

Vera Adema1, Rafael Bejar.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24323981      PMCID： PMC3856955          DOI： 10.3324/haematol.2013.094912

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.

Authors:  Martin Jädersten; Leonie Saft; Alexander Smith; Austin Kulasekararaj; Sabine Pomplun; Gudrun Göhring; Anette Hedlund; Robert Hast; Brigitte Schlegelberger; Anna Porwit; Eva Hellström-Lindberg; Ghulam J Mufti
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.

Authors:  Francesc Solé; Elisa Luño; Carmen Sanzo; Blanca Espinet; Guillermo F Sanz; José Cervera; María José Calasanz; Juan Cruz Cigudosa; Fuensanta Millà; Josep Maria Ribera; Encarna Bureo; Maria Luisa Marquez; Eva Arranz; Lourdes Florensa
Journal:  Haematologica       Date:  2005-09       Impact factor: 9.941

3.  Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.

Authors:  Andres Jerez; Lukasz P Gondek; Anna M Jankowska; Hideki Makishima; Bartlomiej Przychodzen; Ramon V Tiu; Christine L O'Keefe; Azim M Mohamedali; Denise Batista; Mikkael A Sekeres; Michael A McDevitt; Ghulam J Mufti; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

4.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

5.  Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.

Authors:  Marta Fernandez-Mercado; Adam Burns; Andrea Pellagatti; Aristoteles Giagounidis; Ulrich Germing; Xabier Agirre; Felipe Prosper; Carlo Aul; Sally Killick; James S Wainscoat; Anna Schuh; Jacqueline Boultwood
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

6.  Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.

Authors:  Amel Sebaa; Lionel Ades; Fanny Baran-Marzack; Marie-Joelle Mozziconacci; Dominique Penther; Sophie Dobbelstein; Aspasia Stamatoullas; Christian Récher; Thomas Prebet; Soraya Moulessehoul; Pierre Fenaux; Virginie Eclache
Journal:  Genes Chromosomes Cancer       Date:  2012-08-30       Impact factor: 5.006

7.  Clinical effect of point mutations in myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

8.  New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Authors:  Julie Schanz; Heinz Tüchler; Francesc Solé; Mar Mallo; Elisa Luño; José Cervera; Isabel Granada; Barbara Hildebrandt; Marilyn L Slovak; Kazuma Ohyashiki; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Peter Valent; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Stefan Faderl; Sherry Pierce; Michelle M Le Beau; John M Bennett; Peter Greenberg; Ulrich Germing; Detlef Haase
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

9.  Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen E Stevenson; Bennett A Caughey; Omar Abdel-Wahab; David P Steensma; Naomi Galili; Azra Raza; Hagop Kantarjian; Ross L Levine; Donna Neuberg; Guillermo Garcia-Manero; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

10.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Authors:  Benjamin L Ebert; Jennifer Pretz; Jocelyn Bosco; Cindy Y Chang; Pablo Tamayo; Naomi Galili; Azra Raza; David E Root; Eyal Attar; Steven R Ellis; Todd R Golub
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962
View more
  3 in total

Review 1.  Myelodysplastic Syndrome: Diagnosis and Screening.

Authors:  Francisco P Tria; Daphne C Ang; Guang Fan
Journal:  Diagnostics (Basel)       Date:  2022-06-29

Review 2.  Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.

Authors:  Jie Xian; Eric Owusu Obeng; Stefano Ratti; Isabella Rusciano; Maria Vittoria Marvi; Antonietta Fazio; Alessia De Stefano; Sara Mongiorgi; Alessandra Cappellini; Giulia Ramazzotti; Lucia Manzoli; Lucio Cocco; Matilde Yung Follo
Journal:  Cells       Date:  2020-03-12       Impact factor: 6.600

3.  Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity.

Authors:  Junshik Hong; Yoo Jin Lee; Sung Hwa Bae; Jun Ho Yi; Sungwoo Park; Myung Hee Chang; Young Hoon Park; Shin Young Hyun; Joo-Seop Chung; Ji Eun Jang; Joo Young Jung; So-Yeon Jeon; Seo-Young Song; Hawk Kim; Dae Sik Kim; Sung-Hyun Kim; Min Kyoung Kim; Sang Hoon Han; Seonyang Park; Yoo-Jin Kim; Je-Hwan Lee
Journal:  Blood Res       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.